These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8032633)

  • 1. Role of endopeptidase 3.4.24.16 in the catabolism of neurotensin, in vivo, in the vascularly perfused dog ileum.
    Barelli H; Fox-Threlkeld JE; Dive V; Daniel EE; Vincent JP; Checler F
    Br J Pharmacol; 1994 May; 112(1):127-32. PubMed ID: 8032633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo inactivation of neurotensin in dog ileum: major involvement of endopeptidase 24-11.
    Checler F; Kostolanska B; Fox JA
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1040-4. PubMed ID: 2855236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of human endopeptidase 3.4.24.16. Comparison with the porcine counterpart indicates a unique cleavage site on neurotensin.
    Vincent B; Vincent JP; Checler F
    Brain Res; 1996 Feb; 709(1):51-8. PubMed ID: 8869556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological role and degradation processes of neuromedin N in the gastrointestinal tract: an in vitro and in vivo study.
    Barelli H; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE; Vincent JP; Checler F
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1300-7. PubMed ID: 8531096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidases in dog-ileum circular and longitudinal smooth-muscle plasma membranes. Their relative contribution to the metabolism of neurotensin.
    Checler F; Ahmad S; Kostka P; Barelli H; Kitabgi P; Fox JA; Kwan CY; Daniel EE; Vincent JP
    Eur J Biochem; 1987 Jul; 166(2):461-8. PubMed ID: 3301344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral inactivation of neurotensin. Isolation and characterization of a metallopeptidase from rat ileum.
    Barelli H; Vincent JP; Checler F
    Eur J Biochem; 1988 Aug; 175(3):481-9. PubMed ID: 3409880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorus-containing peptides as mixed inhibitors of endopeptidase 3.4.24.15 and 3.4.24.16: effect on neurotensin degradation in vitro and in vivo.
    Vincent B; Dive V; Yiotakis A; Smadja C; Maldonado R; Vincent JP; Checler F
    Br J Pharmacol; 1995 Jul; 115(6):1053-63. PubMed ID: 7582503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catabolism of neurotensin in the epithelial layer of porcine small intestine.
    Shaw C; Göke R; Bunnett NW; Conlon JM
    Biochim Biophys Acta; 1987 Apr; 924(1):167-74. PubMed ID: 3548829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin metabolism in various tissues of central and peripheral origins: ubiquitous involvement of a novel neurotensin degrading metalloendopeptidase.
    Checler F; Barelli H; Kitabgi P; Vincent JP
    Biochimie; 1988 Jan; 70(1):75-82. PubMed ID: 3135845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes.
    Mentlein R; Dahms P
    J Neurochem; 1994 Jan; 62(1):27-36. PubMed ID: 7903352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation.
    Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F
    Br J Pharmacol; 1997 Jun; 121(4):705-10. PubMed ID: 9208137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential catabolic fate of neuromedin N and neurotensin in the canine intestinal mucosa.
    Barelli H; Mao YK; Vincent B; Daniel EE; Vincent JP; Checler F
    Peptides; 1993; 14(3):457-63. PubMed ID: 8332546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent inhibition of endopeptidase 24.16 and endopeptidase 24.15 by the phosphonamide peptide N-(phenylethylphosphonyl)-Gly-L-Pro-L-aminohexanoic acid.
    Barelli H; Dive V; Yiotakis A; Vincent JP; Checler F
    Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):621-5. PubMed ID: 1332678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorimetric assay of the neurotensin-degrading metalloendopeptidase, endopeptidase 24.16.
    Dauch P; Barelli H; Vincent JP; Checler F
    Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):421-6. PubMed ID: 1747117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of endopeptidase 24.16 by dipeptides.
    Dauch P; Vincent JP; Checler F
    Eur J Biochem; 1991 Dec; 202(2):269-76. PubMed ID: 1761032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and properties of a neurotensin-degrading endopeptidase from pig brain.
    Millican PE; Kenny AJ; Turner AJ
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):583-91. PubMed ID: 1905921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidases involved in the catabolism of neurotensin: inhibitor studies using superfused rat hypothalamic slices.
    McDermott JR; Virmani MA; Turner JD; Kidd AM
    Peptides; 1986; 7(2):225-30. PubMed ID: 3526299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
    Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
    Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of endopeptidase 3.4.24.15 to central neurotensin inactivation.
    Vincent B; Jiracek J; Noble F; Loog M; Roques B; Dive V; Vincent JP; Checler F
    Eur J Pharmacol; 1997 Sep; 334(1):49-53. PubMed ID: 9346327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin and neuromedin N undergo distinct catabolic processes in murine astrocytes and primary cultured neurons.
    Vincent B; Vincent JP; Checler F
    Eur J Biochem; 1994 Apr; 221(1):297-306. PubMed ID: 7909519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.